Olivo Alicia C's Form 4 filing
Neogenomics Inc (NEO) · filed Aug 19, 2024
- Accession no.
- 0001077183-24-000141
- Filed
- Aug 19, 2024
- Trade date
- Aug 15, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $16.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Olivo Alicia CCIK 0001951869 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2024 | Common Stock | SSaleDisposed | −1,040 | $16.05 | −$16,692 | 43,813 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.